IL159547A0 - Novel vinyl carboxylic acid derivatives and their use as antidiabetics - Google Patents
Novel vinyl carboxylic acid derivatives and their use as antidiabeticsInfo
- Publication number
- IL159547A0 IL159547A0 IL15954702A IL15954702A IL159547A0 IL 159547 A0 IL159547 A0 IL 159547A0 IL 15954702 A IL15954702 A IL 15954702A IL 15954702 A IL15954702 A IL 15954702A IL 159547 A0 IL159547 A0 IL 159547A0
- Authority
- IL
- Israel
- Prior art keywords
- antidiabetics
- carboxylic acid
- acid derivatives
- vinyl carboxylic
- novel vinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101154 | 2001-07-30 | ||
PCT/DK2002/000471 WO2003011807A1 (en) | 2001-07-30 | 2002-07-05 | Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
Publications (1)
Publication Number | Publication Date |
---|---|
IL159547A0 true IL159547A0 (en) | 2004-06-01 |
Family
ID=8160643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15954702A IL159547A0 (en) | 2001-07-30 | 2002-07-05 | Novel vinyl carboxylic acid derivatives and their use as antidiabetics |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1414778A1 (xx) |
JP (1) | JP2004536150A (xx) |
KR (1) | KR20040019087A (xx) |
CN (1) | CN1537093A (xx) |
BR (1) | BR0211414A (xx) |
CA (1) | CA2452665A1 (xx) |
CZ (1) | CZ2004133A3 (xx) |
HU (1) | HUP0401575A2 (xx) |
IL (1) | IL159547A0 (xx) |
MX (1) | MXPA04000891A (xx) |
NO (1) | NO20040389L (xx) |
PL (1) | PL366401A1 (xx) |
RU (1) | RU2004105956A (xx) |
WO (1) | WO2003011807A1 (xx) |
ZA (1) | ZA200400161B (xx) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1688540A (zh) | 2002-09-05 | 2005-10-26 | 诺沃挪第克公司 | 新颖的乙烯基羧酸衍生物以及它们的治疗用途 |
KR20050055790A (ko) * | 2002-10-28 | 2005-06-13 | 노보 노르디스크 에이/에스 | Ppar 매개 질환의 치료에 유용한 신규 화합물 |
PL376718A1 (pl) * | 2002-10-28 | 2006-01-09 | Novo Nordisk A/S | Nowe związki, ich wytwarzanie i stosowanie |
ITRM20030305A1 (it) * | 2003-06-20 | 2004-12-21 | Sigma Tau Ind Farmaceuti | Preparazione di nuovi derivati di acidi fenil o fenossialchil mono e dicarbossilici utili nel trattamento dell'iperglicemia e dell'ipertrigliceridemia tipiche del diabete del tipo ii. |
JP4928941B2 (ja) * | 2003-09-19 | 2012-05-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 4−((フェノキシアルキル)チオ)−フェノキシ酢酸および類似化合物 |
EP1670744B9 (en) | 2003-09-19 | 2012-09-05 | Janssen Pharmaceutica NV | 4-((phenoxyalkyl)thio)-phenoxyacetic aci ds and analogs |
WO2005105736A1 (en) * | 2004-05-05 | 2005-11-10 | Novo Nordisk A/S | Novel compounds, their preparation and use |
ME02005B (me) | 2005-09-14 | 2012-08-31 | Takeda Pharmaceuticals Co | Inhibitori dipeptidil peptidaze za lečenje dijabetesa |
JO3006B1 (ar) | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
CA2622642C (en) | 2005-09-16 | 2013-12-31 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7943613B2 (en) | 2005-12-22 | 2011-05-17 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
PE20080188A1 (es) | 2006-04-18 | 2008-03-10 | Janssen Pharmaceutica Nv | Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol |
KR100693132B1 (ko) * | 2006-06-23 | 2007-03-14 | 동해전장 주식회사 | 정션박스내에 삽입된 릴레이의 동작 검사 장치 |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US20120168303A1 (en) * | 2011-01-05 | 2012-07-05 | Sueng-Nien Kao | Salt water activated emergency lighting device |
CN103467406B (zh) * | 2013-09-03 | 2014-12-17 | 浙江医药高等专科学校 | 卤素取代的四氮唑羧酸类化合物、其制备方法和用途 |
CN103467407B (zh) * | 2013-09-03 | 2015-04-22 | 浙江医药高等专科学校 | 四氮唑羧酸类化合物及其用途 |
CN103467405B (zh) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | 一类四氮唑羧酸类化合物、其制备方法和用途 |
CN103467408B (zh) * | 2013-09-03 | 2015-01-21 | 浙江医药高等专科学校 | 一类四氮唑羧酸类化合物及其用途 |
CN103467409B (zh) * | 2013-09-03 | 2015-01-07 | 浙江医药高等专科学校 | 取代的四氮唑羧酸类化合物及其用途 |
KR20230054373A (ko) * | 2020-07-22 | 2023-04-24 | 르네오 파마슈티컬스, 인크. | 결정질 ppar-델타 작용제 |
WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0098690B1 (en) * | 1982-06-14 | 1987-09-09 | Takeda Chemical Industries, Ltd. | Vinyl carboxylic acid derivatives, their production and use |
AU2652397A (en) * | 1996-05-13 | 1997-12-05 | Nippon Shinyaku Co. Ltd. | Substituted ethylene compounds and drugs |
JP2002542218A (ja) * | 1999-04-20 | 2002-12-10 | ノボ ノルディスク アクティーゼルスカブ | 新規な化合物、それらの製造および使用 |
CA2395298A1 (en) * | 2000-01-28 | 2001-08-02 | Novo Nordisk A/S | Propionic acid derivatives and their use in the treatment of diabetes and obesity |
-
2002
- 2002-07-05 CN CNA028150996A patent/CN1537093A/zh active Pending
- 2002-07-05 CA CA002452665A patent/CA2452665A1/en not_active Abandoned
- 2002-07-05 CZ CZ2004133A patent/CZ2004133A3/cs unknown
- 2002-07-05 EP EP02745186A patent/EP1414778A1/en not_active Withdrawn
- 2002-07-05 IL IL15954702A patent/IL159547A0/xx unknown
- 2002-07-05 HU HU0401575A patent/HUP0401575A2/hu unknown
- 2002-07-05 JP JP2003517001A patent/JP2004536150A/ja active Pending
- 2002-07-05 MX MXPA04000891A patent/MXPA04000891A/es unknown
- 2002-07-05 RU RU2004105956/04A patent/RU2004105956A/ru not_active Application Discontinuation
- 2002-07-05 BR BR0211414-3A patent/BR0211414A/pt not_active IP Right Cessation
- 2002-07-05 KR KR10-2004-7001417A patent/KR20040019087A/ko not_active Application Discontinuation
- 2002-07-05 PL PL02366401A patent/PL366401A1/xx not_active Application Discontinuation
- 2002-07-05 WO PCT/DK2002/000471 patent/WO2003011807A1/en not_active Application Discontinuation
-
2004
- 2004-01-09 ZA ZA200400161A patent/ZA200400161B/en unknown
- 2004-01-29 NO NO20040389A patent/NO20040389L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0401575A2 (hu) | 2004-11-29 |
CN1537093A (zh) | 2004-10-13 |
RU2004105956A (ru) | 2005-03-27 |
BR0211414A (pt) | 2004-08-17 |
CA2452665A1 (en) | 2003-02-13 |
CZ2004133A3 (cs) | 2004-06-16 |
EP1414778A1 (en) | 2004-05-06 |
WO2003011807A1 (en) | 2003-02-13 |
PL366401A1 (en) | 2005-01-24 |
MXPA04000891A (es) | 2004-05-21 |
NO20040389L (no) | 2004-01-29 |
KR20040019087A (ko) | 2004-03-04 |
ZA200400161B (en) | 2004-08-18 |
JP2004536150A (ja) | 2004-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL159547A0 (en) | Novel vinyl carboxylic acid derivatives and their use as antidiabetics | |
PL367196A1 (en) | Carboxylic acid derivative and salt thereof | |
AU2002251481A1 (en) | Carboxylic acid derivative and salt thereof | |
AU2001287898A1 (en) | Pyrazolopyridines and pyrazolopyridazines as antidiabetics | |
HUP0401647A3 (en) | Novel betha-phenyl-alpha-oxy propionic acid derivatives, processes for their preparation and their use in the preparation of pharmaceutically important compounds | |
PL369567A1 (en) | 1,6-naphthyridine derivatives as antidiabetics | |
PL370244A1 (en) | Dicarboxylic acid derivatives, their preparation and therapeutic use | |
IL154031A0 (en) | Substituted sulfonylaminomethylbenzoic acid derivatives and preparation | |
AU8198901A (en) | Novel heteroaryl derivatives and use thereof as medicaments | |
IL153476A0 (en) | Novel heteroaryl derivatives and the use thereof as pharmaceuticals | |
AU7975701A (en) | Novel heteroaryl derivatives and the use thereof as pharmaceuticals | |
ZA200410054B (en) | Propionic acid derivatives and their use as hPPARsactivators. | |
PL375700A1 (en) | Novel vinyl carboxylic acid derivatives and their therapeutical use | |
HK1081954A1 (en) | Novel 1,4-diazabicycloalkane derivatives, their preparation and use | |
AU2001275677A1 (en) | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | |
AU2001267583A1 (en) | Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments | |
AU2003205558A1 (en) | Thioibotenic acid and derivatives thereof | |
AU2001235437A1 (en) | Isothiazolecarboxylic acid derivatives and their use as microbicides | |
AU6038601A (en) | Amino acid derivatives and their use as medicines | |
IL165612A0 (en) | Novel arylimidazole derivatives preparation and therapeutic uses thereof | |
AU2002212176A1 (en) | Substituted phenylcyclohexane carboxylic acid amides and the use thereof | |
ZA200402308B (en) | NOVEL a-OXYGENATED OR a-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES | |
AU2002308105A1 (en) | Benzoaxathiepin derivatives and their use as medicines | |
PL371468A1 (en) | Carboxylic acid derivative | |
AU2002210989A1 (en) | Cyclopropanecarboxylic acid amide compounds and medicinal use thereof |